RYANX
Price
$136.56
Change
-$0.81 (-0.59%)
Updated
Dec 17 closing price
RYVLX
Price
$606.52
Change
-$5.38 (-0.88%)
Updated
Dec 17 closing price
Ad is loading...

RYANX vs RYVLX

Header iconRYANX vs RYVLX Comparison
Open Charts RYANX vs RYVLXBanner chart's image
Rydex Nova A
Price$136.56
Change-$0.81 (-0.59%)
VolumeN/A
CapitalizationN/A
Rydex NASDAQ-100® 2x Strategy A
Price$606.52
Change-$5.38 (-0.88%)
VolumeN/A
CapitalizationN/A
RYANX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYANX vs. RYVLX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYANX is a StrongBuy and RYVLX is a Buy.

FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.58B vs. RYANX (264M). RYANX pays higher dividends than RYVLX: RYANX (0.58) vs RYVLX (0.00). RYANX was incepted earlier than RYVLX: RYANX (21 years) vs RYVLX (20 years). RYANX is a more actively managed with annual turnover of: 973.00 vs. RYVLX (461.00). RYANX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 49.61 vs. RYANX (40.00). RYVLX return over 5 years is better than : 221.61 vs. RYANX (63.24).
RYANXRYVLXRYANX / RYVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years20 years-
Gain YTD38.85948.28680%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets264M1.58B17%
Annual Yield % from dividends0.580.00-
Returns for 1 year40.0049.6181%
Returns for 3 years9.7034.5928%
Returns for 5 years63.24221.6129%
Returns for 10 years200.46735.2727%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HESAY241.403.29
+1.38%
Hermes International SA
PRMRF20.890.01
+0.06%
Paramount Resources Ltd.
SSREY36.96-0.23
-0.62%
Swiss Re Ltd
PVCT0.13N/A
-0.66%
Provectus Biopharmaceuticals, Inc.
VDMCY5.58-0.33
-5.58%
Vodacom Group Ltd.